Biotechnology

Dr. Kieran Murphy Presents Results of Clinical Trial Demonstrating Positive Effect Protecting DNA From Radiation Exposure

by

TORONTO, May 27, 2023 /PRNewswire/ — Cora Therapeutics, a dynamic life sciences startup based in Toronto, proudly unveils the results of a clinical trial at the Canadian Association of Interventional Radiologists (CAIR) annual meeting in Quebec City. Dr. Kieran Murphy MD, FRCPC, FSIR, Founder, Inventor, and CMO of Cora Therapeutics, announced the efficacy of a … Read more

FDA Roundup: May 26, 2023

by

SILVER SPRING, Md., May 26, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA issued warning letters to firms responsible for two popular flavored, disposable e-cigarette products—Shenzen Innokin Technology Co. Ltd., who make Esco Bars products, and Breeze Smoke … Read more

Novavax’s Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU

by

GAITHERSBURG, Md., May 26, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373) has been recommended for full Marketing Authorization (MA) for use as a primary series in individuals aged 12 and older and as a booster in individuals aged 18 … Read more

ProfoundBio Announces Further Advancement of Lead Programs

by

PRO1160 first patient dosed in the US China NMPA clearance for PRO1184 (rinatabart sesutecan, Rina-S) and PRO1160 to initiate clinical trials Rina-S preliminary clinical data is encouraging SUZHOU, China and WOODINVILLE, Wash., May 26, 2023 /PRNewswire/ — ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics, announced that dosing in the Phase … Read more

Jazz Pharmaceuticals to Host Zanidatamab KOL Investor Webcast on June 2, 2023

by

Zanidatamab data to be featured in oral presentation at ASCO 2023 Webcast to follow on June 2, 2023 at 6:45 p.m. CT DUBLIN, May 25, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host a webcast to review the zanidatamab biliary tract cancers (BTC) data being featured in an oral presentation at the 2023 American … Read more

Ductor and TotalEnergies form JV to develop, build and operate a pipeline of biogas and organic fertilizer projects

by

HELSINKI and ZURICH, May 25, 2023 /PRNewswire/ — Ductor, a leading circular biotechnology company within biogas and organic fertilizers, and TotalEnergies, the global multi-energy company, today announce a new commercial and financial partnership with joint development of production facilities and TotalEnergies equity ownership in Ductor. Bernard and Oliver The two companies have agreed to form … Read more

Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit

by

CAMBRIDGE, Mass., May 24, 2023 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation … Read more

FDA Roundup: May 23, 2023

by

SILVER SPRING, Md., May 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA and the Veterans Health Administration announced a new collaboration to jointly develop emergency preparedness and response tools and protocols intended to help increase medical product … Read more

Des résultats positifs ressortent de l’analyse intermédiaire de l’essai de phase II ‘GEN-001’ Plus avelumab (Bavencio®)

by

SÉOUL, Corée du Sud, 19 mai 2023 /PRNewswire/ — Genome & Company (PDG : Pae, Jisoo), un leader mondial dans le développement de thérapies du microbiome, a annoncé que cet essai de phase II (NCT05419362) se poursuivrait sans modifications pour passer à la deuxième étape, sur la base du résultat positif de l’analyse intermédiaire. La combinaison … Read more

Bayer inaugura loja própria para agricultores de Rio Verde-GO

by

Loja Agro Bayer é piloto da companhia para ampliar sua oferta de soluções no terceiro maior polo do agronegócio SÃO PAULO, 19 de maio de 2023 /PRNewswire/ — A Bayer terá no Brasil projeto piloto de loja física no município de Rio Verde (GO). A Loja Agro Bayer é parte da estratégia de distribuição da … Read more